Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank Disease ID
1 Calcium signaling pathway 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
2 Calcium signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
3 Calcium signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
4 Calcium signaling pathway 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
5 Calcium signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
6 Calcium signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
7 Calcium signaling pathway 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
8 Calcium signaling pathway 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
9 Calcium signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
10 Calcium signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
11 Calcium signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
12 Calcium signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
13 Central carbon metabolism in cancer 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
14 Central carbon metabolism in cancer 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
15 Central carbon metabolism in cancer 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
16 Central carbon metabolism in cancer 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
17 Central carbon metabolism in cancer 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
18 Central carbon metabolism in cancer 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
19 Central carbon metabolism in cancer 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
20 Central carbon metabolism in cancer 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
21 Central carbon metabolism in cancer 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
22 Central carbon metabolism in cancer 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
23 Central carbon metabolism in cancer 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
24 Central carbon metabolism in cancer 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
25 Choline metabolism in cancer 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
26 Choline metabolism in cancer 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
27 Choline metabolism in cancer 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
28 Choline metabolism in cancer 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
29 Choline metabolism in cancer 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
30 Choline metabolism in cancer 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
31 Choline metabolism in cancer 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
32 Choline metabolism in cancer 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
33 Choline metabolism in cancer 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
34 Choline metabolism in cancer 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
35 Choline metabolism in cancer 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
36 Choline metabolism in cancer 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
37 Focal adhesion 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
38 Focal adhesion 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
39 Focal adhesion 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
40 Focal adhesion 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
41 Focal adhesion 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
42 Focal adhesion 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
43 Focal adhesion 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
44 Focal adhesion 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
45 Focal adhesion 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
46 Focal adhesion 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
47 Focal adhesion 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
48 Focal adhesion 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
49 Gap junction 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
50 Gap junction 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
51 Gap junction 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
52 Gap junction 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
53 Gap junction 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
54 Gap junction 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
55 Gap junction 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
56 Gap junction 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
57 Gap junction 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
58 Gap junction 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
59 Gap junction 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
60 Gap junction 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
61 Glioma 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
62 Glioma 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
63 Glioma 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
64 Glioma 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
65 Glioma 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
66 Glioma 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
67 Glioma 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
68 Glioma 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
69 Glioma 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
70 Glioma 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
71 Glioma 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
72 Glioma 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
73 Human papillomavirus infection 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
74 Human papillomavirus infection 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
75 Human papillomavirus infection 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
76 Human papillomavirus infection 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
77 Human papillomavirus infection 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
78 Human papillomavirus infection 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
79 Human papillomavirus infection 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
80 Human papillomavirus infection 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
81 Human papillomavirus infection 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
82 Human papillomavirus infection 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
83 Human papillomavirus infection 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
84 Human papillomavirus infection 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
85 JAK-STAT signaling pathway 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
86 JAK-STAT signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
87 JAK-STAT signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
88 JAK-STAT signaling pathway 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
89 JAK-STAT signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
90 JAK-STAT signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
91 JAK-STAT signaling pathway 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
92 JAK-STAT signaling pathway 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
93 JAK-STAT signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
94 JAK-STAT signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
95 JAK-STAT signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
96 JAK-STAT signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
97 MAPK signaling pathway 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
98 MAPK signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
99 MAPK signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
100 MAPK signaling pathway 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
101 MAPK signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
102 MAPK signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
103 MAPK signaling pathway 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
104 MAPK signaling pathway 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
105 MAPK signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
106 MAPK signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
107 MAPK signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
108 MAPK signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
109 Melanoma 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
110 Melanoma 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
111 Melanoma 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
112 Melanoma 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
113 Melanoma 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
114 Melanoma 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
115 Melanoma 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
116 Melanoma 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
117 Melanoma 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
118 Melanoma 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
119 Melanoma 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
120 Melanoma 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
121 MicroRNAs in cancer 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
122 MicroRNAs in cancer 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
123 MicroRNAs in cancer 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
124 MicroRNAs in cancer 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
125 MicroRNAs in cancer 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
126 MicroRNAs in cancer 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
127 MicroRNAs in cancer 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
128 MicroRNAs in cancer 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
129 MicroRNAs in cancer 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
130 MicroRNAs in cancer 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
131 MicroRNAs in cancer 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
132 MicroRNAs in cancer 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
133 Pathways in cancer 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
134 Pathways in cancer 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
135 Pathways in cancer 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
136 Pathways in cancer 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
137 Pathways in cancer 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
138 Pathways in cancer 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
139 Pathways in cancer 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
140 Pathways in cancer 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
141 Pathways in cancer 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
142 Pathways in cancer 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
143 Pathways in cancer 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
144 Pathways in cancer 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
145 Phospholipase D signaling pathway 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
146 Phospholipase D signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
147 Phospholipase D signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
148 Phospholipase D signaling pathway 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
149 Phospholipase D signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
150 Phospholipase D signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
151 Phospholipase D signaling pathway 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
152 Phospholipase D signaling pathway 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
153 Phospholipase D signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
154 Phospholipase D signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
155 Phospholipase D signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
156 Phospholipase D signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
157 PI3K-Akt signaling pathway 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
158 PI3K-Akt signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
159 PI3K-Akt signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
160 PI3K-Akt signaling pathway 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
161 PI3K-Akt signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
162 PI3K-Akt signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
163 PI3K-Akt signaling pathway 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
164 PI3K-Akt signaling pathway 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
165 PI3K-Akt signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
166 PI3K-Akt signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
167 PI3K-Akt signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
168 PI3K-Akt signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
169 Prostate cancer 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
170 Prostate cancer 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
171 Prostate cancer 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
172 Prostate cancer 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
173 Prostate cancer 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
174 Prostate cancer 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
175 Prostate cancer 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
176 Prostate cancer 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
177 Prostate cancer 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
178 Prostate cancer 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
179 Prostate cancer 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
180 Prostate cancer 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
181 Rap1 signaling pathway 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
182 Rap1 signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
183 Rap1 signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
184 Rap1 signaling pathway 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
185 Rap1 signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
186 Rap1 signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
187 Rap1 signaling pathway 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
188 Rap1 signaling pathway 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
189 Rap1 signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
190 Rap1 signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
191 Rap1 signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
192 Rap1 signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
193 Ras signaling pathway 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
194 Ras signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
195 Ras signaling pathway 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
196 Ras signaling pathway 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
197 Ras signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
198 Ras signaling pathway 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
199 Ras signaling pathway 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
200 Ras signaling pathway 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
201 Ras signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
202 Ras signaling pathway 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
203 Ras signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
204 Ras signaling pathway 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
205 Regulation of actin cytoskeleton 💬
 [1] PDGFRB 💬 Catequentinib 💬 Anlotinib [1] 85 💬
206 Regulation of actin cytoskeleton 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
207 Regulation of actin cytoskeleton 💬
 [1] PDGFRB 💬 Dasatinib 💬 Dasatinib [2] 51, 85 💬
208 Regulation of actin cytoskeleton 💬
 [1] PDGFRB 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
209 Regulation of actin cytoskeleton 💬
 [1] PDGFRB 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
210 Regulation of actin cytoskeleton 💬
 [1] PDGFRB 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
211 Regulation of actin cytoskeleton 💬
 [1] PDGFRB 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
212 Regulation of actin cytoskeleton 💬
 [1] PDGFRB 💬 Seralutinib 💬 Seralutinib [1] 86 💬
213 Regulation of actin cytoskeleton 💬
 [1] PDGFRB 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
214 Regulation of actin cytoskeleton 💬
 [1] PDGFRB 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
215 Regulation of actin cytoskeleton 💬
 [1] PDGFRB 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
216 Regulation of actin cytoskeleton 💬
 [1] PDGFRB 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬

Back to top